OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A
Sunzeyu Huang, Nathaniel J. Stillson, Jonathan E. Sandoval, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 40, pp. 127908-127908
Open Access | Times Cited: 16

Showing 16 citing articles:

DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective
Sannidhi Bhootra, Nandana Jill, Geetha Shanmugam, et al.
Medical Oncology (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 25

Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
Ting Chen, Syrine Mahdadi, Michel Vidal, et al.
Pharmacological Research (2024) Vol. 207, pp. 107328-107328
Open Access | Times Cited: 7

GSK-3484862 targets DNMT1 for degradation in cells
Qin Chen, Bigang Liu, Yang Zeng, et al.
NAR Cancer (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 18

Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors
J.R. Horton, Sarath Pathuri, Kristen Wong, et al.
Structure (2022) Vol. 30, Iss. 6, pp. 793-802.e5
Open Access | Times Cited: 21

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
Vincent G. Sorrentino, Srijan Thota, Edward A. Gonzalez, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 641-641
Open Access | Times Cited: 24

Targeting neuronal epigenomes for brain rejuvenation
Sara Zocher
The EMBO Journal (2024) Vol. 43, Iss. 16, pp. 3312-3326
Open Access | Times Cited: 2

Inhibitors of DNA Methylation
Marie Lopez, Julie Gilbert, Jean Marie Contreras, et al.
Advances in experimental medicine and biology (2022), pp. 471-513
Open Access | Times Cited: 12

First-in-Class Allosteric Inhibitors of DNMT3A Disrupt Protein–Protein Interactions and Induce Acute Myeloid Leukemia Cell Differentiation
Jonathan E. Sandoval, Raghav Ramabadran, Nathaniel J. Stillson, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10554-10566
Closed Access | Times Cited: 11

Inhibitors targeting the PWWP domain-containing proteins
Yunyuan Huang, Boyi Li, Zhibin Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116965-116965
Closed Access | Times Cited: 1

Structural Investigations of Phthalazinone Derivatives as Allosteric Inhibitors of Human DNA Methyltransferase 3A
Ivan Hernandez, Ethan Ward, Thomas R. R. Pettus, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 590-594
Open Access

Toward Understanding Pharmacological Modulation of DNA Methylation
J.R. Horton
Royal Society of Chemistry eBooks (2024), pp. 193-227
Closed Access

GSK-3484862 targets DNMT1 for degradation in cells
Qin Chen, Yang Zeng, Jee Won Hwang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2

In silico study of selective inhibition mechanism of S-adenosyl-L-methionine analogs for human DNA methyltransferase 3A
Nathaniel J. Stillson, Kyle E. Anderson, Norbert O. Reich
Computational Biology and Chemistry (2022) Vol. 102, pp. 107796-107796
Open Access | Times Cited: 2

Small Molecule Inhibitors Targeting Methyltransferase-Like (METTL) Proteins Against Hepatocellular Carcinoma: A Comprehensive Drug Repurposing Approach
Md Niaz Morshed, Md. Sorwer Alam Parvez, Rakibul Islam Akanda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Structural Characterization of Dicyanopyridine Containing DNMT1-Selective, Non-Nucleoside Inhibitors
J.R. Horton, Sarath Pathuri, Kristen Wong, et al.
SSRN Electronic Journal (2022)
Closed Access

Page 1

Scroll to top